Covid-19: Lagos State to begin short clinical trials of Ivermectin

The Lagos State Government has announced that it would begin a short clinical trial to ascertain the efficiency of Ivermectin in the prevention and treatment of COVID-19 infection.

This was disclosed by the State Government in a social media statement on Sunday.

Lagos State Government said it is aware of “numerous international claims that the broad spectrum anti-parasitic agent/medication Ivermectin has shown some efficacy in acting as a sustained prophylaxis in containing/inhibiting the causative virus in SARS CoV-2.”

They added that despite the medication not being approved for the treatment of the virus, “the State Government has however taken the bold step of ensuring we have adequate stocks of Ivermectin”

READ: Cost of Ivermectin soars after research suggest 75% chance of cutting Covid-19 deaths

While this medication has not yet been approved for the broad treatment of the Coronavirus disease, the State Government has however taken the bold step of ensuring we have adequate stocks of Ivermectin

— The Lagos State Govt (@followlasg) January 31, 2021

READ: Covid-19: Lagos State says testing at public health facilities cannot be used for travel purposes

What you should know 

• Recall Nairametrics reported that the cost of Ivermectin has risen after research suggests a 75% chance of cutting Covid-19 deaths.
• “At N200 per tablet, a pack of 500 tablets could go for as high as N100,000. From all indications, the prices are unstable and could be purchased from as little as N20,000 per pack of 500 tablets to as high as N100,000. It all depends on demand and supply and who is under pressure to get a ‘cure’”, a pharmacist told Nairametrics.